Cogent Biosciences, Inc. COGT Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s operating cash flow?
- Cogent Biosciences, Inc. (COGT) reported operating cash flow of -$86.88M in Q1 2026.
- How has Cogent Biosciences, Inc.'s operating cash flow changed year-over-year?
- Cogent Biosciences, Inc.'s operating cash flow decreased by 30.6% year-over-year, from -$66.51M to -$86.88M.
- What is the long-term trend for Cogent Biosciences, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s operating cash flow has grown at a 45.6% compound annual growth rate (CAGR), from -$58.76M to -$264.44M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.